Carol A Burke Selected Research

Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)

5/2022	Phase II trial of weekly erlotinib dosing to reduce duodenal polyp burden associated with familial adenomatous polyposis.
1/2022	Malignancy risk in individuals with familial adenomatous polyposis receiving biologics and immunomodulators.
1/2022	Chemoprevention Considerations in Patients with Hereditary Colorectal Cancer Syndromes.
1/2021	Long-Term Outcomes of Pancreas-Sparing Duodenectomy for Duodenal Polyposis in Familial Adenomatous Polyposis Syndrome.
1/2021	Chemoprevention in familial adenomatous polyposis: past, present and future.
1/2021	Incidence and Management of Rectal Cuff and Anal Transitional Zone Neoplasia in Patients With Familial Adenomatous Polyposis.
1/2021	Risks, Benefits, and Effects on Management for Biopsy of the Papilla in Patients With Familial Adenomatous Polyposis.
10/2020	Eflornithine plus Sulindac for Prevention of Progression in Familial Adenomatous Polyposis.
8/2020	Endoscopic Surveillance of Duodenal Polyposis After Total Gastrectomy in Familial Adenomatous Polyposis.
10/2019	Comparison of pancreas-sparing duodenectomy (PSD) and pancreatoduodenectomy (PD) for the management of duodenal polyposis syndromes.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carol A Burke Research Topics

Disease

23	Neoplasms (Cancer) 05/2022 - 06/2004
23	Polyps 05/2022 - 06/2004
23	Adenoma (Adenomas) 01/2021 - 03/2003
17	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 05/2022 - 04/2003
10	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 04/2003
5	Gastric Polyposis 01/2022 - 01/2021
4	Pancreatitis 04/2022 - 04/2018
4	Hemorrhage 01/2022 - 02/2016
4	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2022 - 04/2013
3	Aggressive Fibromatosis (Desmoid) 11/2022 - 12/2018
3	Duodenal Neoplasms (Duodenal Cancer) 01/2021 - 08/2020
3	Disease Progression 01/2021 - 01/2017
2	Microsatellite Instability 11/2021 - 04/2013
2	Thyroid Neoplasms (Thyroid Cancer) 01/2021 - 12/2010
2	Stomach Neoplasms (Stomach Cancer) 08/2020 - 10/2018
2	Multiple Hamartoma Syndrome (Cowden's Disease) 12/2015 - 12/2010
2	Obesity 03/2015 - 12/2006
2	Colonic Neoplasms (Colon Cancer) 04/2014 - 12/2006
2	Peutz-Jeghers Syndrome (Polyposis, Hamartomatous Intestinal) 07/2005 - 01/2004
1	Pancreas Divisum 04/2022
1	Hamartoma 01/2022
1	Rheumatic Diseases (Rheumatism) 01/2022
1	Juvenile polyposis syndrome 01/2022
1	Turcot syndrome 11/2021
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2021
1	Nausea 01/2021
1	Colonic Diseases 01/2021
1	Headache (Headaches) 01/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021
1	Abdominal Pain (Pain, Abdominal) 01/2021
1	Colonic Pseudo-Obstruction (Ogilvie Syndrome) 01/2020
1	Exocrine Pancreatic Insufficiency 10/2019
1	Overweight 01/2019
1	Gallstones (Gallstone) 04/2018
1	Acute Cholecystitis 04/2018
1	Deglutition Disorders (Dysphagia) 01/2017
1	Inflammation (Inflammations) 11/2014
1	Chronic Disease (Chronic Diseases) 10/2014

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2014
6	CalciumIBA 01/2019 - 04/2003
5	Folic Acid (Vitamin M)FDA LinkGeneric 03/2009 - 04/2003
4	Biological ProductsIBA 01/2022 - 04/2003
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2009 - 03/2003
3	Sulindac (Copal)FDA LinkGeneric 05/2022 - 08/2016
3	acceleratory factor from growth hormone (AcG)IBA 01/2021 - 03/2009
3	Eflornithine (Ornidyl)FDA Link 10/2020 - 02/2016
3	Vitamin D FDA LinkGeneric 01/2019 - 10/2015
3	Celecoxib (Celebrex)FDA Link 01/2017 - 06/2010
2	Immunologic Factors (Immunomodulators)IBA 01/2022 - 01/2022
2	TensinsIBA 01/2022 - 12/2010
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2022 - 12/2010
2	Pharmaceutical PreparationsIBA 01/2021 - 10/2020
2	Cholecalciferol (Vitamin D3)FDA Link 01/2019 - 10/2015
2	AnnexinsIBA 12/2016 - 04/2014
2	antineoplaston A10 (A 10)IBA 12/2016 - 04/2014
2	Calcibiotic Root Canal SealerIBA 04/2013 - 09/2012
2	Capsules (Microcapsules)IBA 07/2005 - 01/2004
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 05/2022
1	Monoclonal AntibodiesIBA 01/2022
1	VaccinesIBA 01/2022
1	Sirolimus (Rapamycin)FDA Link 01/2022
1	Lipase (Acid Lipase)FDA Link 01/2021
1	O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA 01/2021
1	Neostigmine (Neostigmine Bromide)IBA 01/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	Apolipoproteins B (ApoB)IBA 01/2019
1	LipidsIBA 01/2019
1	Vitamin A (Retinol)FDA LinkGeneric 01/2019
1	Cadherins (E-Cadherin)IBA 10/2018
1	Codon (Codons)IBA 10/2018
1	sodium thiosulfate FDA Link 01/2017
1	Biological FactorsIBA 10/2016
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 08/2016
1	PolyaminesIBA 08/2016
1	Estrogens (Estrogen)FDA Link 03/2015
1	C-Reactive ProteinIBA 11/2014
1	25-hydroxyvitamin DIBA 10/2014
1	hydroxide ionIBA 10/2014
1	Indicators and Reagents (Reagents)IBA 09/2014
1	TransferasesIBA 07/2014
1	MicroRNAs (MicroRNA)IBA 07/2014
1	Suppositories (Vaginal Suppositories)IBA 07/2014
1	Messenger RNA (mRNA)IBA 04/2014
1	theasinensin AIBA 09/2012

Therapy/Procedure

12	Chemoprevention 01/2022 - 04/2003
9	Colectomy 11/2022 - 08/2010
7	Therapeutics 04/2022 - 03/2015
4	Restorative Proctocolectomy 11/2022 - 04/2015
2	Gastrectomy 08/2020 - 10/2018
1	Secondary Prevention 01/2022
1	Cholecystectomy 01/2022
1	Patient Transfer (Patient Dumping) 01/2021
1	Adjuvant Chemotherapy 11/2020
1	Radiotherapy 01/2020
1	Drug Therapy (Chemotherapy) 01/2020
1	Decompression 01/2020
1	Pancreaticoduodenectomy 10/2019
1	Laparoscopic Cholecystectomy 04/2018
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 02/2016
1	Bariatric Surgery 02/2016